212 related articles for article (PubMed ID: 23541441)
21. Telomerase insufficiency induced telomere erosion accumulation in successive generations in dyskeratosis congenita family.
He C; Jing S; Dai C; Tu C; Tan Z; Du J; Lu GX; Lin G; Zeng S
Mol Genet Genomic Med; 2019 Jul; 7(7):e00709. PubMed ID: 31119896
[TBL] [Abstract][Full Text] [Related]
22. CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.
Westin ER; Khodadadi-Jamayran A; Pham LK; Tung ML; Goldman FD
G3 (Bethesda); 2023 Nov; 13(11):. PubMed ID: 37717172
[TBL] [Abstract][Full Text] [Related]
23. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.
Zhong F; Savage SA; Shkreli M; Giri N; Jessop L; Myers T; Chen R; Alter BP; Artandi SE
Genes Dev; 2011 Jan; 25(1):11-6. PubMed ID: 21205863
[TBL] [Abstract][Full Text] [Related]
24. Dyskeratosis congenita.
Vulliamy T; Dokal I
Semin Hematol; 2006 Jul; 43(3):157-66. PubMed ID: 16822458
[TBL] [Abstract][Full Text] [Related]
25. The short and long telomere syndromes: paired paradigms for molecular medicine.
Stanley SE; Armanios M
Curr Opin Genet Dev; 2015 Aug; 33():1-9. PubMed ID: 26232116
[TBL] [Abstract][Full Text] [Related]
26. Syndromes of telomere shortening.
Armanios M
Annu Rev Genomics Hum Genet; 2009; 10():45-61. PubMed ID: 19405848
[TBL] [Abstract][Full Text] [Related]
27. Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience.
Jyonouchi S; Forbes L; Ruchelli E; Sullivan KE
Pediatr Allergy Immunol; 2011 May; 22(3):313-9. PubMed ID: 21284747
[TBL] [Abstract][Full Text] [Related]
28. Dyskeratosis congenita: a genetic disorder of many faces.
Kirwan M; Dokal I
Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
[TBL] [Abstract][Full Text] [Related]
29. Engineered telomere degradation models dyskeratosis congenita.
Hockemeyer D; Palm W; Wang RC; Couto SS; de Lange T
Genes Dev; 2008 Jul; 22(13):1773-85. PubMed ID: 18550783
[TBL] [Abstract][Full Text] [Related]
30. Telomere-driven diseases and telomere-targeting therapies.
Martínez P; Blasco MA
J Cell Biol; 2017 Apr; 216(4):875-887. PubMed ID: 28254828
[TBL] [Abstract][Full Text] [Related]
31. Dyskeratosis congenita.
Dokal I
Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
[TBL] [Abstract][Full Text] [Related]
32. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex.
Sarper N; Zengin E; Kılıç SÇ
Pediatr Blood Cancer; 2010 Dec; 55(6):1185-6. PubMed ID: 20979174
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
34. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
[TBL] [Abstract][Full Text] [Related]
35. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
[TBL] [Abstract][Full Text] [Related]
36. Telomerase and cancer stem cells.
Armanios M; Greider CW
Cold Spring Harb Symp Quant Biol; 2005; 70():205-8. PubMed ID: 16869755
[TBL] [Abstract][Full Text] [Related]
37. Human diseases of telomerase dysfunction: insights into tissue aging.
Garcia CK; Wright WE; Shay JW
Nucleic Acids Res; 2007; 35(22):7406-16. PubMed ID: 17913752
[TBL] [Abstract][Full Text] [Related]
38. A role for sister telomere cohesion in telomere elongation by telomerase.
Houghtaling BR; Canudas S; Smith S
Cell Cycle; 2012 Jan; 11(1):19-25. PubMed ID: 22157096
[TBL] [Abstract][Full Text] [Related]
39. Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP).
Lagunas AM; Francis M; Maniar NB; Nikolova G; Wu J; Crowe DL
Mol Cancer Res; 2019 Jul; 17(7):1480-1492. PubMed ID: 31043491
[TBL] [Abstract][Full Text] [Related]
40. [Bone marrow failure due to telomere associated gene mutation].
Yamaguchi H; Dan K
Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
